Beyond Basic Beta Content Hub Understanding Moat Index’s Valuation Conviction By VanEckDecember 12, 2021
Beyond Basic Beta Content Hub Using Biotechnology Stocks to Help Navigate the Ongoing COVID Crisis By VanEckDecember 11, 2021
Beyond Basic Beta Content Hub Write a Prescription for Pharma Dividends With PPH By Tom LydonDecember 9, 2021
Beyond Basic Beta Content Hub Municipal Bonds Are Going Green, and Investors Can Benefit By Tom LydonDecember 7, 2021
Beyond Basic Beta Content Hub With Demand Soaring, Get Answers on Green Bonds By Tom LydonDecember 6, 2021
Beyond Basic Beta Content Hub After Omicron Market Drubbing, Some MOAT Holdings Look Cheap By Tom LydonDecember 3, 2021
Beyond Basic Beta Content Hub Omicron Variant Could Be Potent for Pharma Stocks, ETFs By Tom LydonDecember 2, 2021
Beyond Basic Beta Content Hub A Real Asset ETF Strategy Is a One-Stop Shop to Fight Inflation By Max ChenDecember 1, 2021
Beyond Basic Beta Content Hub BDC Finances on Solid Footing, Says Ratings Agency By Tom LydonDecember 1, 2021
Beyond Basic Beta Content Hub Time to Take Technical Look at Emerging Markets Debt ETF By Tom LydonNovember 30, 2021
Beyond Basic Beta Content Hub EM Rate Hikes Could Be Promising for This Bond ETF By Tom LydonNovember 29, 2021
